PT  - JOURNAL ARTICLE
AU  - Böttcher, Lucas
AU  - D’Orsogna, Maria R.
AU  - Chou, Tom
TI  - A statistical model of COVID-19 testing in populations: effects of sampling bias and testing errors
AID  - 10.1101/2021.05.22.21257643
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.22.21257643
4099  - http://medrxiv.org/content/early/2021/05/26/2021.05.22.21257643.short
4100  - http://medrxiv.org/content/early/2021/05/26/2021.05.22.21257643.full
AB  - We develop a statistical model for the testing of disease prevalence in a population. The model assumes a binary test result, positive or negative, but allows for biases in sample selection and both type I (false positive) and type II (false negative) testing errors. Our model also incorporates multiple test types and is able to distinguish between retesting and exclusion after testing. Our quantitative framework allows us to directly interpret testing results as a function of errors and biases. By applying our testing model to COVID-19 testing data and actual case data from specific jurisdictions, we are able to estimate and provide uncertainty quantification of indices that are crucial in a pandemic, such as disease prevalence and fatality ratios.Competing Interest StatementThe authors have declared no competing interest.Funding StatementLB acknowledges financial support from the Swiss National Fund (P2EZP2_191888). The authors also acknowledge financial support from the Army Research Office (W911NF-18-1-0345), the NIH (R01HL146552), and the National Science Foundation (DMS-1814364, DMS-1814090).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:n/aAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOur source codes are publicly available at https://github.com/lubo93/disease-testing. https://github.com/lubo93/disease-testing